|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
34.840 +0.060 (+0.173%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 7,433,559 | 14.266% | 6,505,501 | 4,511,217 | 4,434,378 | 4,401,501 |
| Cost of Sales | (660,786) | 14.082% | (579,218) | (535,455) | (398,582) | (415,680) |
| Gross Profit | 6,772,773 | 14.284% | 5,926,283 | 3,975,762 | 4,035,796 | 3,985,821 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 3,688,152 | 18.279% | 3,118,186 | 1,499,883 | 1,509,124 | 1,547,056 | |
| Taxation | (553,223) | 40.891% | (392,661) | (211,035) | (211,148) | (256,466) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 3,134,929 | 15.021% | 2,725,525 | 1,288,848 | 1,297,976 | 1,290,590 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (510,760) | 38.392% | (369,068) | (341,480) | (123,146) | (37,134) |
| Depreciation & Amortisation | 197,274 | -8.993% | 216,767 | 184,878 | 158,167 | 135,251 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 53.000 | 15.217% | 46.000 | 22.000 | 22.000 | 22.000 |
| DPS (cts) | 21.133 | -- | 18.347 | 6.472 | 4.377 | 0.000 |
| Dividend Payout Ratio (%) | 39.873% | -- | 39.885% | 29.418% | 19.896% | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 5.229 | -- | 4.701 | 4.075 | 3.567 | 3.161 |
| Remarks: | Real time quote last updated: 27/10/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,134,929 |
| %Change | 15.021% |
| EPS / (LPS) | RMB 0.530 |
| NBV Per Share (¥) | RMB 5.229 |